GW Pharmaceuticals plc
(NASDAQ GM: GWPH)
Rigrodsky Law, P.A. is investigating GW Pharmaceuticals plc (“GW Pharmaceuticals”) regarding possible breaches of fiduciary duties and other violations of law related to GW Pharmaceuticals’ agreement to be acquired by Jazz Pharmaceuticals plc (“Jazz Pharmaceuticals”). Under the terms of the agreement, GW Pharmaceuticals’ shareholders will receive $20.00 worth of shares of Jazz Pharmaceuticals and $200.00 in cash per share.